{
  "analysis_mode": "HISTORICAL_ONLY",
  "symbol": "HEMO.L",
  "generated_at": "2026-01-12T05:21:36.196239Z",
  "top_card": {
    "ticker": "HEMO.L",
    "company_name": "Hemogenyx Pharmaceuticals Plc",
    "sector": "Healthcare",
    "market_cap_gbp": 37516193,
    "days_active": 178,
    "apex_score_100": 59,
    "confidence_score_100": 40,
    "ai_final_score_25": 16,
    "ai_strength": "STRONG",
    "timing_regime": "EARLY_BUILD",
    "action": "WATCH",
    "thesis_one_liner": "WATCH - EARLY_BUILD timing with 59/100 opportunity score"
  },
  "enrichment": {
    "company_info": {
      "name": "Hemogenyx Pharmaceuticals Plc",
      "sector": "Healthcare",
      "industry": "Biotechnology",
      "exchange": "LSE",
      "market": "MAIN",
      "currency": "GBP",
      "risk_tier": "Low Risk",
      "current_market_cap": 37516193,
      "current_close_price": 621.0
    },
    "basics": {
      "ticker": "HEMO.L",
      "current_price": 621.0,
      "ath": 6160.0,
      "atl": 124.0,
      "ath_date": "2020-08-26",
      "atl_date": "2025-07-15",
      "week_52_high": 1800.0,
      "week_52_low": 124.0,
      "week_52_high_date": "2025-09-17",
      "week_52_low_date": "2025-07-15",
      "drawdown_from_ath_pct": 89.92,
      "data_start": "2020-01-02",
      "data_end": "2026-01-09",
      "total_bars": 1521
    },
    "latest_signal": {
      "date": "2025-07-15",
      "scan_date": "2026-01-09",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "price": 130.0,
      "drawdown_pct": 89.17,
      "ai_score": 13.0,
      "rsi": 7.6,
      "cycle_position": 0.0909,
      "holding_period_days": 178,
      "current_pnl_pct": 377.69,
      "rally_state": "pulling_back",
      "distance_from_high_pct": -59.81,
      "Rally_Count": 1,
      "days_since_last_high": 25,
      "last_high_date": "2025-12-17",
      "lock_in_reached": true,
      "lock_in_date": "2025-09-18",
      "best_rally_pct": 1088.46
    },
    "best_historical_signal": {
      "signal_date": "2025-07-15",
      "signal_type": "DEEP CRASH BOTTOM",
      "signal_color": "GREEN",
      "entry_price": 130.0,
      "peak_price": 1800.0,
      "peak_date": "2025-09-17",
      "rally_pct": 1284.62,
      "days_to_peak": 64,
      "ai_score": 13.0
    },
    "all_historical_signals": [
      {
        "signal_id": "HEMO.L_2021-04-26",
        "signal_date": "2021-04-26",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1160.0,
        "current_price": 621.0,
        "current_return_pct": -46.47,
        "best_rally_pct": 36.38,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1721,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-04-27",
        "signal_date": "2021-04-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1060.0,
        "current_price": 621.0,
        "current_return_pct": -41.42,
        "best_rally_pct": 49.25,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1720,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-04-30",
        "signal_date": "2021-04-30",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 1060.0,
        "current_price": 621.0,
        "current_return_pct": -41.42,
        "best_rally_pct": 49.25,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 4,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1717,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-05-18",
        "signal_date": "2021-05-18",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 720.0,
        "current_price": 621.0,
        "current_return_pct": -13.75,
        "best_rally_pct": 119.72,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 8,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1699,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-05-19",
        "signal_date": "2021-05-19",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 740.0,
        "current_price": 621.0,
        "current_return_pct": -16.08,
        "best_rally_pct": 113.78,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 9,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1698,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-05-26",
        "signal_date": "2021-05-26",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 660.0,
        "current_price": 621.0,
        "current_return_pct": -5.91,
        "best_rally_pct": 139.7,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 7,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1691,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-11-16",
        "signal_date": "2021-11-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 676.0,
        "current_price": 621.0,
        "current_return_pct": -8.14,
        "best_rally_pct": 134.02,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 6,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1517,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-12-14",
        "signal_date": "2021-12-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 652.0,
        "current_price": 621.0,
        "current_return_pct": -4.75,
        "best_rally_pct": 142.64,
        "best_rally_date": "2024-02-09",
        "rally_state": "accumulating",
        "Rally_Count": 7,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1489,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2021-12-15",
        "signal_date": "2021-12-15",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 604.0,
        "current_price": 621.0,
        "current_return_pct": 2.81,
        "best_rally_pct": 161.92,
        "best_rally_date": "2024-02-09",
        "rally_state": "pulling_back",
        "Rally_Count": 10,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1488,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2022-03-04",
        "signal_date": "2022-03-04",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 501.6,
        "current_price": 621.0,
        "current_return_pct": 23.8,
        "best_rally_pct": 215.39,
        "best_rally_date": "2024-02-09",
        "rally_state": "pulling_back",
        "Rally_Count": 11,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1409,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2022-03-07",
        "signal_date": "2022-03-07",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 450.0,
        "current_price": 621.0,
        "current_return_pct": 38.0,
        "best_rally_pct": 251.56,
        "best_rally_date": "2024-02-09",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1406,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2022-03-09",
        "signal_date": "2022-03-09",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 480.0,
        "current_price": 621.0,
        "current_return_pct": 29.38,
        "best_rally_pct": 229.58,
        "best_rally_date": "2024-02-09",
        "rally_state": "pulling_back",
        "Rally_Count": 8,
        "distance_from_high_pct": -60.75,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 1404,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-06-17",
        "signal_date": "2024-06-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 535.6,
        "current_price": 621.0,
        "current_return_pct": 15.94,
        "best_rally_pct": 188.46,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 573,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-06-20",
        "signal_date": "2024-06-20",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 524.0,
        "current_price": 621.0,
        "current_return_pct": 18.51,
        "best_rally_pct": 194.85,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 570,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-06-27",
        "signal_date": "2024-06-27",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 516.0,
        "current_price": 621.0,
        "current_return_pct": 20.35,
        "best_rally_pct": 199.42,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 5,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 563,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-10-14",
        "signal_date": "2024-10-14",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 464.0,
        "current_price": 621.0,
        "current_return_pct": 33.84,
        "best_rally_pct": 232.97,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 454,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-10-16",
        "signal_date": "2024-10-16",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 450.0,
        "current_price": 621.0,
        "current_return_pct": 38.0,
        "best_rally_pct": 243.33,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 4,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 452,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-11-11",
        "signal_date": "2024-11-11",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 464.0,
        "current_price": 621.0,
        "current_return_pct": 33.84,
        "best_rally_pct": 232.97,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 426,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-11-25",
        "signal_date": "2024-11-25",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 372.4,
        "current_price": 621.0,
        "current_return_pct": 66.76,
        "best_rally_pct": 314.88,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 3,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 412,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2024-12-17",
        "signal_date": "2024-12-17",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 350.0,
        "current_price": 621.0,
        "current_return_pct": 77.43,
        "best_rally_pct": 341.43,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 390,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-03-11",
        "signal_date": "2025-03-11",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 196.5,
        "current_price": 621.0,
        "current_return_pct": 216.03,
        "best_rally_pct": 686.26,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 306,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-03-12",
        "signal_date": "2025-03-12",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 186.75,
        "current_price": 621.0,
        "current_return_pct": 232.53,
        "best_rally_pct": 727.31,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 305,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-06-25",
        "signal_date": "2025-06-25",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 152.25,
        "current_price": 621.0,
        "current_return_pct": 307.88,
        "best_rally_pct": 914.78,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 200,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-06-26",
        "signal_date": "2025-06-26",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 154.25,
        "current_price": 621.0,
        "current_return_pct": 302.59,
        "best_rally_pct": 901.62,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 199,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-06-27",
        "signal_date": "2025-06-27",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 153.25,
        "current_price": 621.0,
        "current_return_pct": 305.22,
        "best_rally_pct": 908.16,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 198,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-06-30",
        "signal_date": "2025-06-30",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 153.25,
        "current_price": 621.0,
        "current_return_pct": 305.22,
        "best_rally_pct": 908.16,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 195,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-01",
        "signal_date": "2025-07-01",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 153.25,
        "current_price": 621.0,
        "current_return_pct": 305.22,
        "best_rally_pct": 908.16,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 194,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-02",
        "signal_date": "2025-07-02",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 153.25,
        "current_price": 621.0,
        "current_return_pct": 305.22,
        "best_rally_pct": 908.16,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 193,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-04",
        "signal_date": "2025-07-04",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 153.25,
        "current_price": 621.0,
        "current_return_pct": 305.22,
        "best_rally_pct": 908.16,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 191,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-10",
        "signal_date": "2025-07-10",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 145.0,
        "current_price": 621.0,
        "current_return_pct": 328.28,
        "best_rally_pct": 965.52,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 185,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-11",
        "signal_date": "2025-07-11",
        "signal_type": "CRASH ZONE BOTTOM",
        "signal_color": "YELLOW",
        "entry_price": 142.25,
        "current_price": 621.0,
        "current_return_pct": 336.56,
        "best_rally_pct": 986.12,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 2,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 184,
        "status": "historical"
      },
      {
        "signal_id": "HEMO.L_2025-07-15",
        "signal_date": "2025-07-15",
        "signal_type": "DEEP CRASH BOTTOM",
        "signal_color": "GREEN",
        "entry_price": 130.0,
        "current_price": 621.0,
        "current_return_pct": 377.69,
        "best_rally_pct": 1088.46,
        "best_rally_date": "2025-09-18",
        "rally_state": "pulling_back",
        "Rally_Count": 1,
        "distance_from_high_pct": -59.81,
        "days_since_last_high": 25,
        "lock_in_reached": true,
        "age_days": 180,
        "status": "historical"
      }
    ],
    "stats": {
      "total_signals": 32,
      "win_rate_pct": 100.0,
      "avg_rally_pct": 597.61,
      "median_rally_pct": 398.82,
      "best_rally_pct": 1284.62,
      "worst_rally_pct": 146.0
    },
    "splits": [],
    "split_risk": {
      "split_detected": false,
      "risk_level": "NONE",
      "confidence": "HIGH"
    },
    "data_quality": {
      "price_reliability": "RELIABLE",
      "pnl_reliability": "RELIABLE",
      "overall_confidence": "HIGH"
    },
    "risk_flags": [
      "EXTREME_DRAWDOWN",
      "FREQUENT_CRASHES"
    ],
    "last_updated": "2026-01-11 18:22:58 UTC"
  },
  "decision_summary": {
    "why_it_matters": [
      "APEX 59/100 indicates strong opportunity quality",
      "Timing regime: EARLY_BUILD",
      "Historical profile: 1 rallies, 1088% best run"
    ],
    "main_risk": "Confidence 40/100 - full data loaded",
    "watch_next": [
      "RNS catalysts (funding/operational updates)",
      "Volume expansion confirmation",
      "Timing regime change signals"
    ]
  },
  "triangulation": {
    "rns": {
      "has_data": true,
      "ticker": "HEMO.L",
      "latest": [
        {
          "title": "Update on Admission of Shares",
          "announcement_date": "22nd Dec 2025",
          "release_time": "8:00 am",
          "source": "RNS",
          "content": "22 Dec 2025 08:00\nRNS Number : 3721M\nHemogenyx Pharmaceuticals PLC\n22 December 2025\n22 December 2025\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx Pharmaceuticals\" or the \"Company\")\nUpdate on Admission of Shares\nHemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, provides an update to the admission of new ordinary shares as announced on 18 December 2025.\nThe FCA has notified the Company that the admission hearing has been scheduled for the earliest available date being 5 January 2026, with admission expected to occur on or around 8.00 a.m. on 6 January 2026.\nAll other details outlined in the Company's announcement of 18 December 2025 remain unchanged.\nEnquiries:\nHemogenyx Pharmaceuticals plc\nhttps://hemogenyx.com\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\nheadquarters@hemogenyx.com\nPeter Redmond, Director\npeter.redmond@hemogenyx.com\nSP Angel Corporate Finance LLP\nTel: +44 (0)20 3470 0470\nMatthew Johnson, Vadim Alexandre, Adam Cowl\nAlbR Capital Limited\nTel: +44 (0)20 7469 0930\nLucy Williams, Duncan Vasey, Charles Goodfellow\nAbout Hemogenyx Pharmaceuticals plc\nHemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in\nLondon\n, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in\nNew York City\n.\nThe Company is a clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as platform technologies that it uses as engines for novel product development.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nUPDEAEAEADASFFA"
        },
        {
          "title": "Issue of Equity",
          "announcement_date": "18th Dec 2025",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "18 Dec 2025 07:00\nRNS Number : 0124M\nHemogenyx Pharmaceuticals PLC\n18 December 2025\n18 December 2025\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx Pharmaceuticals\" or the \"Company\")\nIssue of Equity arising from the Exercise of Warrants, Restricted Stock Unit Award and Deed of Variation And Total Voting Rights\nIntroduction\nHemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has issued and allotted an aggregate of 123,377 new Ordinary Shares of 1p each (\"Ordinary Shares\") in the Company for the reasons set out in this announcement.\nWarrant Shares\nThe Company has received notices to exercise warrants over 105,556 new Ordinary Shares at an exercise price of \u00a31.80 (the \"\nWarrant Shares\n\") raising \u00a3190,000 for the Company.\nRestricted Stock Units\nThe Company also announces the vesting of 6,000 Restricted Stock Units, the grant of which was announced on 29 October 2025.\nThe Company has therefore issued and allotted an aggregate of 6,000 new Ordinary Shares (the \"\nRSU Shares\n\").\nDeed of Variation\nFurther, the Company has issued and allotted 11,821 new Ordinary Shares further to obligations imposed on it under the terms of a Deed of Variation entered into by the Company on 16 September 2025 (the \"\nVariation Shares\n\"). The Variation Shares are being issued at a price of \u00a38.84 per Variation Share.\nAdmission and Total Voting Rights\nApplication will be made for the Warrant Shares, the RSU Shares and the Variation Shares (which will rank\npari passu\nin all respects with the existing Ordinary Shares of the Company), to be admitted to the\nFCA official list and to trading on the equity shares (transition) category of the Official List maintained by the FCA and to trading on the main market for listed securities of the LSE\n, which is expected to occur on or around 8.00 a.m. on 23 December 2025 (\"Admission\").\nUpon Admission, the total number of issued shares and the total number of voting rights in the Company will be 6,041,255.\nThe above figure of 6,041,255 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\nThe Company will keep the market informed of future developments as trials proceed.\nEnquiries:\nHemogenyx Pharmaceuticals plc\nhttps://hemogenyx.com\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\nheadquarters@hemogenyx.com\nPeter Redmond, Director\npeter.redmond@hemogenyx.com\nSP Angel Corporate Finance LLP\nTel: +44 (0)20 3470 0470\nMatthew Johnson, Vadim Alexandre, Adam Cowl\nAlbR Capital Limited\nTel: +44 (0)20 7469 0930\nLucy Williams, Duncan Vasey, Charles Goodfellow\nAbout Hemogenyx Pharmaceuticals plc\nHemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in\u00a0London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in\u00a0New York City\u00a0.\nThe Company is a clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as platform technologies that it uses as engines for novel product development.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nIOEDDLFFELLLFBB"
        },
        {
          "title": "Holding(s) in Company",
          "announcement_date": "18th Sep 2025",
          "release_time": "1:16 pm",
          "source": "RNS",
          "content": "18 Sep 2025 13:16\nRNS Number : 9287Z\nHemogenyx Pharmaceuticals PLC\n18 September 2025\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BQVXM815\nIssuer Name\nHEMOGENYX PHARMACEUTICALS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nDavid John Smith\nCity of registered office (if applicable)\nGrimsby\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nName\nCity of registered office\nCountry of registered office\nTransact Nominees Limited\nLondon\nEngland\nInteractive Investor Services Nominees Limited\nManchester\nEngland\n5. Date on which the threshold was crossed or reached\n01-Sep-2025\n6. Date on which Issuer notified\n18-Sep-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n3.037600\n0.000000\n3.037600\n143594\nPosition of previous notification (if applicable)\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BQVXM815\n142898\n696\n3.022900\n0.014700\nSub Total 8.A\n143594\n3.037600%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nDavid Smith\n3.037600\n3.037600%\nDavid Smith\nGHC Property Services Limited\n0.014700\n0.014700%\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n13. Place Of Completion\nHull, England\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BQVXM815\nIssuer Name\nHEMOGENYX PHARMACEUTICALS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nDavid John Smith\nCity of registered office (if applicable)\nGrimsby\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nName\nCity of registered office\nCountry of registered office\nGHC Property Services Limited\nGrimsby\nEngland\nCopier Systems Limited\nScunthorpe\nEngland\nHBP Monpellier Limited\nCarlisle\nEngland\nKamarin Computers Limited\nScunthorpe\nEngland\nHBP Systems Limited\nScunthorpe\nEngland\nTransact Nominees Limited\nLondon\nEngland\nInteractive Investor Services Nominees Limited\nManchester\nEngland\n5. Date on which the threshold was crossed or reached\n04-Sep-2025\n6. Date on which Issuer notified\n18-Sep-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n4.761400\n0.000000\n4.761400\n240162\nPosition of previous notification (if applicable)\n3.037600\n0.000000\n3.037600\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BQVXM815\n170021\n70141\n3.370800\n1.390600\nSub Total 8.A\n240162\n4.761400%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nDavid Smith\n4.761400\n4.761400%\nDavid Smith\nGHC Property Services Limited\n0.289200\n0.289200%\nDavid Smith\nHBP Systems Limited\n0.275400\n0.275400%\nDavid Smith\nKamarin Computers Limited\n0.275400\n0.275400%\nDavid Smith\nHBP Monpellier Limited\n0.275400\n0.275400%\nDavid Smith\nCopier Systems Limited\n0.275400\n0.275400%\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n13. Place Of Completion\nHull, England\nTR-1: Standard form for notification of major holdings\n1. Issuer Details\nISIN\nGB00BQVXM815\nIssuer Name\nHEMOGENYX PHARMACEUTICALS PLC\nUK or Non-UK Issuer\nUK\n2. Reason for Notification\nAn acquisition or disposal of voting rights\n3. Details of person subject to the notification obligation\nName\nDavid John Smith\nCity of registered office (if applicable)\nGrimsby\nCountry of registered office (if applicable)\nUnited Kingdom\n4. Details of the shareholder\nName\nCity of registered office\nCountry of registered office\nGHC Property Services Limited\nGrimsby\nEngland\nCopier Systems Limited\nScunthorpe\nEngland\nHBP Monpellier Limited\nCarlisle\nEngland\nKamarin Computers Limited\nScunthorpe\nEngland\nHBP Systems Limited\nScunthorpe\nEngland\nTransact Nominees Limited\nLondon\nEngland\nInteractive Investor Services Nominees Limited\nManchester\nEngland\n5. Date on which the threshold was crossed or reached\n08-Sep-2025\n6. Date on which Issuer notified\n18-Sep-2025\n7. Total positions of person(s) subject to the notification obligation\n% of voting rights attached to shares (total of 8.A)\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\nTotal of both in % (8.A + 8.B)\nTotal number of voting rights held in issuer\nResulting situation on the date on which threshold was crossed or reached\n5.163200\n0.000000\n5.163200\n260426\nPosition of previous notification (if applicable)\n4.761400\n0.000000\n4.761400\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n8A. Voting rights attached to shares\nClass/Type of shares ISIN code(if possible)\nNumber of direct voting rights (DTR5.1)\nNumber of indirect voting rights (DTR5.2.1)\n% of direct voting rights (DTR5.1)\n% of indirect voting rights (DTR5.2.1)\nGB00BQVXM815\n190285\n70141\n3.772600\n1.390600\nSub Total 8.A\n260426\n5.163200%\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\nType of financial instrument\nExpiration date\nExercise/conversion period\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n% of voting rights\nSub Total 8.B1\n8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))\nType of financial instrument\nExpiration date\nExercise/conversion period\nPhysical or cash settlement\nNumber of voting rights\n% of voting rights\nSub Total 8.B2\n9. Information in relation to the person subject to the notification obligation\n2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)\nUltimate controlling person\nName of controlled undertaking\n% of voting rights if it equals or is higher than the notifiable threshold\n% of voting rights through financial instruments if it equals or is higher than the notifiable threshold\nTotal of both if it equals or is higher than the notifiable threshold\nDavid Smith\n5.163200\n5.163200%\nDavid Smith\nGHC Property Services Limited\n0.289200\n0.289200%\nDavid Smith\nHBP Systems Limited\n0.275400\n0.275400%\nDavid Smith\nKamarin Computers Limited\n0.275400\n0.275400%\nDavid Smith\nHBP Monpellier Limited\n0.275400\n0.275400%\nDavid Smith\nCopier Systems Limited\n0.275400\n0.275400%\n10. In case of proxy voting\nName of the proxy holder\nThe number and % of voting rights held\nThe date until which the voting rights will be held\n11. Additional Information\n12. Date of Completion\n13. Place Of Completion\nHull, England\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nHOLUWAURVRUKAAR"
        },
        {
          "title": "Total Voting Rights",
          "announcement_date": "31st Dec 2024",
          "release_time": "7:00 am",
          "source": "RNS",
          "content": "31 Dec 2024 07:00\nRNS Number : 6637R\nHemogenyx Pharmaceuticals PLC\n31 December 2024\n31 December 2024\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx Pharmaceuticals\" or the \"Company\")\nTotal Voting Rights\nHemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 31 December 2024 consists of 3,504,539 ordinary shares of 1 pence each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 3,504,539.\nThe figure of 3,504,539 ordinary shares may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their investment in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.\nEnquiries:\nHemogenyx Pharmaceuticals plc\nhttps://hemogenyx.com\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\nheadquarters@hemogenyx.com\nPeter Redmond, Director\npeter.redmond@hemogenyx.com\nSP Angel Corporate Finance LLP\nTel: +44 (0)20 3470 0470\nMatthew Johnson, Vadim Alexandre, Adam Cowl\nPeterhouse Capital Limited\nTel: +44 (0)20 7469 0930\nLucy Williams, Duncan Vasey, Charles Goodfellow\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nTVREADAEDFKLFAA"
        },
        {
          "title": "Publication of Prospectus",
          "announcement_date": "19th Nov 2025",
          "release_time": "11:47 am",
          "source": "RNS",
          "content": "19 Nov 2025 11:47\nRNS Number : 2074I\nHemogenyx Pharmaceuticals PLC\n19 November 2025\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN OR INTO ANY JURISDICTION WHERE TO DO\u00a0SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION\nThis announcement is an advertisement and not a prospectus. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not purchase any transferable securities referred to in this announcement except on the basis of information contained in the prospectus (the \"\nProspectus\n\") in its final form that is published by Hemogenyx Pharmaceuticals plc in connection with the admission of new ordinary shares in the capital of the Company (the \"\nNew\nOrdinary Shares\n\") to listing in equity shares (transition) category of the Official List of the Financial Conduct Authority (the \"\nFCA\n\") and to trading on the main market for listed securities (the \"\nMain Market\n\") of London Stock Exchange plc (the \"\nLondon Stock Exchange\n\") following conversion of certain convertible loan notes and exercise of certain warrants.\n19\nNovember 2025\nHemogenyx Pharmaceuticals plc\n(\"Hemogenyx Pharmaceuticals\" or the \"Company\")\nPublication of Prospectus\nThe Company is pleased to announce today the publication of a Prospectus in relation to the admission of 116,982 new ordinary shares of 0.01 pence each to be issued upon conversion of convertible loan notes issued by the Company on 31 August 2025 (the \"\nConvertible Loan Notes\nShares\n\") and 439,629 new ordinary shares of 0.01 pence each to be issued following the exercise of certain of the warrants issued by the Company during 2025 (the \"\nWarrant Shares\n\") (together the \"\nNew Ordinary Shares\n\") to listing in the equity shares (transition) category of the Official List of the FCA and to trading on the Main Market of the London Stock Exchange (together, \"\nAdmission\n\").\nIt is expected that Admission will become effective,\u00a0and unconditional dealings in the New Ordinary Shares will commence on 24 November 2025.\nThe Prospectus will be available from the Company's registered office at\n6 Heddon Street, London W1B 4BT, United Kingdom\nand online at\nhttps://hemogenyx.com\n(subject to applicable securities laws).\nAn electronic copy of the Prospectus will also be submitted to the National Storage Mechanism and should be available shortly for inspection at\nhttps://data.fca.org.uk/#/nsm/nationalstoragemechanism\n.\nEnquiries:\nHemogenyx Pharmaceuticals plc\nhttps://hemogenyx.com\nDr Vladislav Sandler, Chief Executive Officer & Co-Founder\nheadquarters@hemogenyx.com\nPeter Redmond, Director\npeter.redmond@hemogenyx.com\nSP Angel Corporate Finance LLP\nTel: +44 (0)20 3470 0470\nMatthew Johnson, Vadim Alexandre, Adam Cowl\nPeterhouse Capital Limited\nTel: +44 (0)20 7469 0930\nLucy Williams, Duncan Vasey, Charles Goodfellow\nAbout Hemogenyx Pharmaceuticals plc\nHemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx LLC and Immugenyx LLC, located in New York City.\nThe Company is a clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as engines for novel product development.\n.\nThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact\nrns@lseg.com\nor visit\nwww.rns.com\n.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our\nPrivacy Policy\n.\nEND\nPDIFKLFFEFLZFBE"
        }
      ],
      "themes": [
        "operations"
      ]
    },
    "social": {
      "has_data": true,
      "buzz_level": "HIGH",
      "post_count": 375,
      "sentiment_breakdown": {
        "positive": 0.0,
        "neutral": 100.0,
        "negative": 0.0
      }
    },
    "trends": {
      "has_data": true,
      "current_interest": 0,
      "momentum_score": -23.3,
      "trend_direction": "DOWN",
      "intelligence_signal": "DEAD_TICKER",
      "activity_level": "DEAD"
    },
    "volatility": {
      "atr_normalized": null,
      "stddev_20d": null
    },
    "risk_flags": {
      "split_risk_level": "NONE",
      "halt_risk": "NONE",
      "penny_stock_risk": "NONE"
    }
  },
  "ai_insights": {
    "available": false,
    "reason": "LLM module not loaded or analysis failed"
  },
  "scoring_breakdown": {
    "apex_factors": [
      "Technical quality: +16 (AI_Technical_Score=13.0/20)",
      "Drawdown reversion potential: +18 (Drawdown_Pct=89.2%)",
      "Volume confirmation: +10 (Relative_Volume=6.2)",
      "Pattern reliability: +5 (Rally_Count=1.0)",
      "Upside history: +20 (best_rally_pct=1088%)",
      "Recent exhaustion: -10 (best_rally=1088%, days_since_high=25.0)"
    ],
    "technical_score": {
      "points": 16,
      "ai_score": 13.0,
      "reason": "AI Technical Score 13.0/20 translates to 16/25 points"
    },
    "drawdown_score": {
      "points": 18,
      "drawdown_pct": 89.17,
      "reason": "Drawdown of 89.2% gives 18/20 points"
    },
    "volume_score": {
      "points": 10,
      "rel_volume": 6.15,
      "reason": "Relative volume 6.15x gives 10 points"
    },
    "pattern_score": {
      "points": 5,
      "rally_count": 1.0,
      "reason": "1.0 historical rallies gives 5/15 points"
    },
    "upside_score": {
      "points": 20,
      "best_rally_pct": 1088.46,
      "reason": "Best rally of 1088% gives 20/20 points"
    },
    "penalties": {
      "total": -10,
      "items": [
        "Recent exhaustion: -10 (best_rally=1088%, days_since_high=25.0)"
      ]
    }
  },
  "reasons_buy_sell": {
    "reasons_to_buy": [
      {
        "reason": "Historically strong runner - massive upside when it moves",
        "tag": "HIGH",
        "evidence": [
          "best_rally_pct=1088%",
          "Rally_Count=1.0"
        ]
      },
      {
        "reason": "Early stage positioning offers best R:R if catalysts appear",
        "tag": "MED",
        "evidence": [
          "timing_regime=EARLY_BUILD",
          "current_return_pct=377.7%"
        ]
      },
      {
        "reason": "Proven winner - previously hit lock-in target",
        "tag": "MED",
        "evidence": [
          "lock_in_reached=True"
        ]
      }
    ],
    "reasons_to_sell": [
      {
        "reason": "Triangulation not loaded (RNS/social/trends missing)",
        "tag": "HIGH",
        "evidence": [
          "analysis_mode=HISTORICAL_ONLY",
          "confidence_capped_at_65"
        ]
      },
      {
        "reason": "Stale signal - not for active trading",
        "tag": "HIGH",
        "evidence": [
          "status=historical"
        ]
      }
    ]
  },
  "trade_plan": {
    "trader_plan": {
      "style": "Watch / Starter",
      "action": "Wait for base + catalyst confirmation; starter position only",
      "sizing": "0-1% until CONFIRMED",
      "risk": "Invalidation = breaks recent lows / dilution / suspension",
      "profit_taking": "Scale out 25% at +15%, 25% at +50%, runner above"
    },
    "investor_plan": {
      "allowed": false,
      "thesis_conditions": "Unlock after AI triangulation + CONFIRMED timing",
      "hold_window": "N/A",
      "risk_management": "N/A"
    }
  },
  "exhaustion": {
    "regime": "EARLY_BUILD",
    "run_multiple": 0.35,
    "current_run_pct": 377.69,
    "avg_historical_run_pct": 1088.46
  },
  "history_snapshot": {
    "previous_report_date": null,
    "score_change": null,
    "confidence_change": null,
    "new_events_count": 0,
    "new_rns_titles": []
  },
  "commentary": {
    "executive_summary": "This report runs in HISTORICAL-ONLY mode: triangulation (RNS/social/trends) not loaded. The setup shows EARLY_BUILD timing with 59/100 APEX score. Historical data shows 1 rallies averaging 1088% upside. Current position: +377.7%. Your edge comes from waiting for AI Engine confirmation instead of blind entry.",
    "bull_case": [
      "Strong historical rally behavior (1088% best run)",
      "Early regime often offers best risk/reward"
    ],
    "bear_case": [
      "Monitor for breakdown signals"
    ],
    "timing_translation": "Early accumulation phase. Watch for confirmation before committing size.",
    "confidence_explained": "Confidence 40/100 reflects full data quality with triangulation loaded."
  },
  "data_quality": {
    "sources_present": {
      "snapshot_json": false,
      "daily_enrichment_row": true,
      "historical_profile": false,
      "metadata": true,
      "triangulation_events": true,
      "ai_insights": false
    },
    "missing_data": [
      "AI insights from Groq LLM"
    ],
    "confidence_impact": "HIGH",
    "disclaimer": "Data provided as-is. Not financial advice. AIM micro-caps carry significant volatility risk."
  }
}